Everything tagged "semiconductors" across research, earnings, and macro.
134 articles
ON Semiconductor is emerging from a cyclical reset with improving demand, accelerating AI data center exposure, and early traction in Treo. The stock looks constructive for investors willing to underwrite execution risk and valuation.
FormFactor is benefiting from record revenue, stronger HBM demand, and rising exposure to AI infrastructure test complexity. The stock looks attractive on execution, but valuation already reflects much of the progress.
FormFactor’s selloff looks disconnected from the business underneath it. Record Q1 revenue, HBM-driven demand, and margin expansion make this one of the cleaner AI rebound setups heading into the next earnings report.
Intel is showing real operational progress with revenue growth, improving yields, and stronger segment performance, but the foundry ramp and capital intensity still make this a disciplined Hold.
UMC is showing a stronger recovery than its valuation suggests, led by 22nm/28nm growth, record 22nm revenue, and a net cash balance sheet. The main debate is whether specialty-node momentum can offset cyclical margin pressure.
Cerebras got sold like demand had cracked, but the latest quarter said the opposite. With 92% core revenue growth and major OpenAI and AWS validation, CBRS looks like a margin scare that the market may have overpunished.
SOLS looks like a stock getting punished for deal shock more than for a broken core business. The acquisition risk is real, but the selloff has run ahead of a company that just posted 10% quarterly sales growth, reaffirmed guidance, and still carries constructive analyst support.
Micron has evolved from a cyclical memory name into a higher-quality AI infrastructure supplier with record profitability, strong customer commitments, and rising visibility. The report supports a Buy as HBM demand, richer mix, and tighter supply drive earnings power.
Arm is posting 20%+ annual growth as royalty strength and AI data center demand accelerate, but the stock still trades at a demanding valuation. The business quality is excellent, yet the shares look more attractive on pullbacks than at current levels.
Astera Labs is turning AI infrastructure demand into rapid revenue and profit growth, but the stock’s valuation remains stretched. The business is strong, the balance sheet is clean, and the shares already discount a lot of future success.
Marvell is emerging as a major AI infrastructure beneficiary, with data center revenue now 76% of sales and management guiding for roughly 40% growth in fiscal 2027. The stock still screens expensive, so the upside depends on execution across interconnect, switching, and custom silicon.
Solstice Advanced Materials combines refrigerant conversion, nuclear exposure, and semiconductor materials into a specialty materials platform with improving growth. Q1 sales rose 10% year over year, but valuation and margin execution remain the key debate.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator